Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 115 are a HOLD (36.05%), 181 are a BUY (56.74%), 23 are a SELL (7.21%).
Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 62.47% that have a potential upside of 34.25% achieved within 261 days.
Salveen Richter’s has documented 606 price targets and ratings displayed on 50 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 21-Mar-2025.
Analyst best performing recommendations are on ALLO (ALLOGENE THERAPEUTICS).
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS) at 10/7/2021. The price target of $20 was fulfilled within 1 day with a profit of $4.38 (17.97%) receiving and performance score of 179.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$20
$2.93 (17.16%)
$20
26 days ago
(07-Mar-2025)
16/21 (76.19%)
$2.39 (13.57%)
172
Buy
$27
$9.93 (58.17%)
$27
1 months 6 days ago
(27-Feb-2025)
7/21 (33.33%)
$7.66 (39.61%)
118
Buy
$28
$10.93 (64.03%)
$28
1 months 6 days ago
(27-Feb-2025)
0/6 (0%)
$8.66 (44.78%)
Buy
$28
$10.93 (64.03%)
$28
1 months 6 days ago
(27-Feb-2025)
25/37 (67.57%)
$8.66 (44.78%)
486
Hold
$22
$4.93 (28.88%)
$24
1 months 22 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Which stock is Salveen Richter is most bullish on?
Which stock is Salveen Richter is most reserved on?
What Year was the first public recommendation made by Salveen Richter?